Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000038638Phase 4Recruiting
Phase 4, randomised, double-blind trial in Cardiac valve disease (VHD) comparing TTMP block with ropivacaine with TTMP block with saline (placebo) (2 arms). Primary endpoints: Interval between extubation and first PCIA bolus injection, Cumulative sufentanil consumption and 1 more. Started Oct 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000038638.